Bridging the gap between innovation and capital
Venrock Ventures
Focus on Biotech Therapeutic Companies
Program
Originally established as the venture capital arm of the Rockefeller family in 1969, Venrock partners with entrepreneurs to build some of the world’s most disruptive and successful companies. With a primary focus on technology and healthcare, Venrock’s portfolio companies include 10X Genomics, Apple Computer, AveXis, Check Point Software, CloudFlare, Dollar Shave Club, Gilead Sciences, Idec Pharma, Illumina, Intel, Millennium Pharma, and Nest.
Event
LaunchBio, Citrin Cooperman, and Silicon Valley Bank, a Division of First Citizens Bank, with support by Fondation Ipsen, are pleased to announce their next Investor Connect virtual event with Venrock.
Venrock is currently investing out of Venrock 10, a $650M fund. On the biotech/therapeutics side of the practice, the firm is modality- and therapeutic-area-agnostic. Venrock invests in great people, doing great science, and building platforms or programs that will dramatically improve the standard of care for patients and prefers first-in-class and platform-enabled modality innovation.
Applications will be selected based on meeting the following criteria:
Geography
Open to investments in North America
Company type
Early-stage biotech companies focused on therapeutics, medtech, medical devices and digital tech..
Modalities of Interest
- Small molecules
- Biologics
- Protein-based therapeutics
- RNA-based therapeutics
- Gene therapies
- Gene editing technologies
- Cell therapies
- Regenerative medicine & tissue engineering
- Vaccines
- Radiopharmaceuticals
- AI/ML-Enabled
Preferred Areas of Interest
- Women’s health and osteoporosis
- Precision immunology
- Induced proximity pharmacology
- Neurodegenerative and neuroinflammatory diseases
- Cardiomyopathy and rare/genetic cardiac diseases
Stage
Companies seeking funding for Pre-Seed, Seed, and Series A.
Qualifying start-ups can apply here today.
Applications are accepted on a rolling basis. Learn more about LaunchBio’s Investor Connect series, in partnership with Citrin Cooperman and Silicon Valley Bank, a division of First Citizens Bank.